Fig. 2From: EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approachesKaplan–Meier analysis. Disease-free survival (DFS) and EZH2 expression (a, b ), EED expression (c) and SUZ12 expression (d)Back to article page